Flexible outsourcing models for companies of all sizes
PAREXEL offers innovative outsourcing models that help biopharmaceutical companies of all sizes accelerate product development, reduce costs, mitigate risk, and achieve their business objectives. These flexible relationships are customized to provide our clients with the greatest value, based on their goals and objectives. Working with PAREXEL, our clients are able to greatly increase efficiency by focusing their internal resources on key priorities such as discovery research and product marketing, while using PAREXEL’s resources and expertise to support specific areas of development or commercialization throughout the development cycle. PAREXEL’s services include therapeutic area expertise, clinical trial experience, eClinical technologies, global patient and investigator resources, and regulatory and commercialization knowledge.
PAREXEL leads the way in delivering flexible outsourcing models that help biopharmaceutical companies accomplish their goals at every stage of clinical development. With 30 years of experience serving the pharmaceutical industry, we have the breadth and depth of expertise to create customized solutions that are a perfect fit for every client – whether your company is an emerging research venture, a growing mid-size business, or a global enterprise. Outsourcing partnerships can be particularly valuable for smaller companies that may lack the internal clinical, regulatory or commercialization resources to move their products forward from the lab to the market. Equally important, every PAREXEL biopharmaceutical client – emerging, mid-size and large – benefits from our proven best practices and high quality standards that help ensure the success of your development efforts.
Designing the right model to accomplish your goals
In recent years, outsourcing agreements between biopharmaceutical companies and CROs have moved beyond the traditional transactional and project-by-project approaches to encompass more complex models that can deliver higher levels of cost reductions and time savings in both development and commercialization through stronger relationships focused on common goals. PAREXEL works closely with every client to determine the best model, and tailors that model to meet the specific needs of each company.
By understanding and embracing the benefits of these flexible outsourcing models – and by working with PAREXEL as an outsourcing partner of choice to determine the right approach to accomplish their development and commercialization goals – biopharmaceutical companies of all sizes can maximize their resources, accelerate product development, and gain a competitive edge at a time when even a small advantage can deliver large marketplace dividends.
For more information contact us
